Alpha MED Scientific engineers, manufactures, and markets
MED64 Microelectrode array systems. In 1997, Panasonic
leveraged their electronics expertise to develop and launch the
original MED64 as the first commercially available in-vitro
microelectrode array system.
Our mission is to enrich electrophysiologists with our industry leading expertise in electronics design and manufacturing.
MED64 systems provide multi-point extracellular electrophysiological measurements that provide rich data useful for exploring cutting edge neuroscience and cardiac research. MED64 systems employ a novel electrophysiological method for recording electrical activity from cells using an array of planer microelectrodes embedded in a glass substrate. Scientists in fields such as neuroscience, stem cell biology, safety pharmacology,
toxicology, and drug discovery and screening take advantage of the ease of use and industry leading sensitivity of MED64 systems to answer important scientific questions.
The MED64 is central to driving advancements in biology and medicine.
|Company name||Alpha MED Scientific Inc.|
|Headquarters||209, 7-15, Saito-asagi 7-chome, Ibaraki, Osaka 567-0085
|President||CEO and CTO: Hideyasu Jiko|
|Capitalization||7 million yen|
|Incorporated||September 18, 2009|
|Lines of Business||Develops, manufactures, and provide technical supports for the MED64 System and its associated products.|
|Matsushita Electric Industrial Co., Ltd. (Panasonic Corporation) developed MED Probe as a part of its Brain Computer Project.|
|1997||Launched MED8 System.|
|1999||Launched MED64 System (Separate type). Launched MED64 System (Integrated type).|
|2002||Alpha MED Sciences Co., Ltd. was formed and inherited all MED64 business from Matsushita.|
|2009||Alpha MED Scientific Inc. was formed and inherited all MED64 business from
Alpha MED Sciences Co., Ltd.
Launched MED64-Basic System.
|2014||Launched series of medium throughput system, MED64-Allegro, MED64-Quad II, and MED64-Plex 4/8|
|2016||Acquired by SCREEN Holdings Co., Ltd.|